The foot orthotic insoles market focuses on specialized shoe inserts designed to support, align, or improve the function of the foot. These insoles can be prefabricated or custom-made and are commonly used to relieve pain, correct posture, treat conditions such as plantar fasciitis or flat feet, and enhance comfort for athletes or individuals who stand for long periods. Growth is driven by the rising prevalence of foot disorders, diabetes-related complications, and sports injuries, along with increasing awareness of preventive foot care and the benefits of proper biomechanics. Technological advancements—such as 3D printing for custom orthotics and the use of lightweight, durable materials—are further expanding market opportunities.
The global foot orthotic insoles market size was valued at USD 4.22 billion in 2024 and is projected to grow from USD 4.51 billion in 2025 to USD 7.16 billion by 2032, exhibiting a CAGR of 6.8% during the forecast period. North America dominated the foot orthotic insoles market in 2024, accounting for a 42.89% share, driven by the high prevalence of foot disorders, growing awareness of personalized orthotic solutions, and the rising adoption of advanced insole technologies across the region.
In October 2022, Hanger, Inc. announced the completion of its previously announced transaction (dated 21 July 2022) to be acquired by Patient Square Capital, a healthcare investment firm.